FIELD: medicine, pharmaceutics.
SUBSTANCE: invention aims at a composition for treating pulmonary hypertension which contains an active agent consisting of 0.001 mg/ml to 20 mg/ml of an ACE inhibitor and additionally containing at least one humidifier. It is isotonic and has the pH value within 3 to 8. It is acceptable to administer the composition by inhalations into a mammal in need thereof. According to the invention, the compositions can represent a solution or a suspension, and preferentially, it is acceptable to administer them by spraying. The present invention also aims at a kit for treating a mammal suffering pulmonary hypertension. 2 primary claims, 12 secondary claims.
EFFECT: preparing the composition for treating pulmonary hypertension.
1 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHODS OF TREATING PULMONARY HYPERTENSION | 2012 |
|
RU2599490C2 |
| TARGETING AMINOACID LIPIDS | 2013 |
|
RU2654210C2 |
| AQUEOUS AEROSOL PREPARATION | 2004 |
|
RU2363449C2 |
| PHARMACEUTICAL COMPOSITION AND METHOD FOR TREATING HYPERTENSION | 2011 |
|
RU2571284C2 |
| HUMAN ALDOSTERONE SYNTHASE (CYP11B2) INHIBITORS | 2023 |
|
RU2824362C1 |
| INTRODUCTION OF ILOPROST IN FORM OF AEROSOL BOLUSES | 2012 |
|
RU2605849C2 |
| HUMAN CYTOCHROME 11B2 INHIBITORS | 2022 |
|
RU2789610C1 |
| COMPOSITIONS, CONTAINING CYCLIC PEPTIDES AND METHODS OF APPLYING THEREOF | 2009 |
|
RU2555357C2 |
| INHALATION FORMULATION CONTAINING SULFOALKYL ETHER GAMMA-CYCLODEXTRIN AND CORTICOSTEROID | 2004 |
|
RU2390330C2 |
| APPLICATION OF ORGANIC COMPOUNDS | 2005 |
|
RU2426532C2 |
